The Meeting Brought Together Many Nations
The meeting was held at the WHO Collaborating Center which has been located in the Natural Products Research Institute, Seoul National University, Seoul, Republic of Korea (hereafter NPRI Center) since its designation in 1979. This institution facilitated two major initiatives for providing global standardization of TCM: (i) a proposal for establishment of the Forum on Harmonization of Herbal Medicines; and (ii) a proposal for development of the Treatment Guideline on Evidence-based Traditional Medicine.
Following the agenda on the quality standard of herbal materials and preparations, an epoch on the milestone of modernizing TCM therapy, an initiative was introduced for establishing guidelines of standard therapy practiced in TCM. There have been two serious stumbling blocks; one is a lack of standard diagnostic methodology for various diseases and syndromes in TCM practice. Therefore, each TCM doctor can diagnose subjectively with disease and syndromes. Consequently, poorly repeatable diagnoses can be made. Such a lack of standard methodology may produce a 'trial and error' therapy in practice. In this situation, one can hardly expect a standard guideline for TCM therapy. In order to work out these problems, the NPRI Center proposed that the Regional Office should formally invite an expert working group meeting and discuss issues on examining the feasibility of establishing a standard guideline for TCM therapy. Immediate action was taken by the Regional Office, and the expert meeting with the title of 'The Informal Consultation on the Development of Treatment Guidelines on Evidence-based Traditional Medicine' organized by the Regional Office and the NPRI Center was held in Seoul on May 27-29, 2004 . Experts from TCM and complementary and alternative medicine (CAM), regulatory agencies, conventional medical (Western medicine) and traditional medical educational institutes, governmental policy makers from China, Korea, Japan, Taiwan, the USA and a special group of editorial staff members from eCAM gathered and produced the following outcome, summarized as follows. 
Diseases of High Priority
To develop treatment guidelines for evidence-based TM, participants from China, Japan and Korea submitted lists of target diseases based on their own TM development strategies. Since all countries were not represented, a list of diseases was submitted by the Regional Office to include the whole western Pacific region. Based on the above recommendation, the Regional Office took prompt action as the first step to organize an expert working group meeting in Beijing in October, 2004, on common TCM terminology that is essential for developing the Guidelines.
China
CAM has evolved as a part of conventional medicine over the past decade. TCM is playing an important role in CAM, and it is an urgent task to develop a global standard of TCM practice and herbal medicines as well as for mutual recognition and understanding. To achieve the goal, efforts have been made to push forward with the standardization of TCM by international collaboration through the WHO's activities. (ii) Searching databases (Medline, Napralert, STN, Agricola, Cochrane, and others) (iii) Information on herbal formulae as pharmaceutical preparations registered to regional regulatory agencies C. Review of abstracts and full texts (i) Review of abstracts; determination of total number and significance of publications (ii) Selection of information (classic and modern articles) for detailed study based on quality of literature (iii) Review of full texts; determination of total number and significance of publications. Quality of texts will be evaluated using the following parameters: (a) Well-controlled clinical trials applying Good Clinical Practice (GCP). (b) Clinical papers based on case reports.
II. Formation of an Expert

